help button home button JAMIA Hate scrolling?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Einbinder, J. S.
Right arrow Articles by Scully, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Einbinder, J. S.
Right arrow Articles by Scully, K.
Journal of the American Medical Informatics Association 9:S34-S38 (2002)
© 2002 American Medical Informatics Association


Article

Using a Clinical Data Repository to Estimate the Frequency and Costs of Adverse Drug Events

Jonathan S. Einbinder, MD, MPH and Kenneth Scully, MS

Affiliations of the authors: Department of Health Evaluation Sciences, University of Virginia Health System, Charlottesville, Virginia.

Abstract

As a result of increased attention to medical errors, many institutions are contemplating increased use of information technology and clinical decision support. We conducted a retrospective analysis to estimate the frequency and cost of adverse drug events (ADEs) for inpatients at the University of Virginia. Applying published criteria for the detection of potential adverse events, we used a clinical data warehouse to identify patients and cases with potential ADEs. Again using published criteria, we then estimated the actual number of adverse drug events and preventable adverse drug events, as well as their attributable costs and excess length of stay. Our results showed a higher estimate (10.4-11.5 events per 100 admissions) for ADEs than seen in the ADE Prevention Study, highlighting the importance of considering the generalizability of published ADE studies to other settings. Our analysis demonstrates that retrospective analysis can be an efficient and powerful technique to evaluate rules and criteria used to detect ADEs and to assess their impact.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Medical Informatics Association.